Mark W. Sawicki, Chief Scientific Officer of Cryoport, Inc. ($CYRX), made two open market sales of common shares in the last year, totaling $22,526. His most recent sale occurred on March 24, 2025. These transactions rank 10,970th among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per insider. Sawicki reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1341 | $8.18 | 102,356.0000 | 50,071,665 | 1.29% | 0.00% |
| March 14, 2026 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Common Stock | 22845 | $0.00 | 106,932.0000 | 50,071,665 | 27.17% | 0.05% |
| March 14, 2026 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Stock Option (right to buy) | 68534 | $0.00 | 68,534.0000 | 50,071,665 | 9999.99% | 0.14% |
| March 16, 2026 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 3235 | $8.00 | 103,697.0000 | 50,071,665 | 3.03% | 0.01% |
| March 24, 2025 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1349 | $6.94 | 84,087.0000 | 49,349,624 | 1.58% | 0.00% |
| March 14, 2025 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Common Stock | 9000 | $0.00 | 87,528.0000 | 49,349,624 | 11.46% | 0.02% |
| March 14, 2025 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Stock Option (right to buy) | 24000 | $0.00 | 24,000.0000 | 49,349,624 | 9999.99% | 0.05% |
| March 17, 2025 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 2092 | $6.29 | 85,436.0000 | 49,349,624 | 2.39% | 0.00% |
| March 9, 2025 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Common Stock | 2667 | $0.00 | 80,111.0000 | 49,349,624 | 3.44% | 0.01% |
| March 10, 2025 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1583 | $4.88 | 78,528.0000 | 49,349,624 | 1.98% | 0.00% |
| March 9, 2025 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Restricted Stock Rights | 2667 | $0.00 | 0.0000 | 49,349,624 | 100.00% | 0.01% |
| March 25, 2024 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1367 | $17.54 | 77,444.0000 | 48,737,377 | 1.73% | 0.00% |
| March 9, 2024 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Restricted Stock Rights | 2666 | $0.00 | 2,667.0000 | 48,737,377 | 49.99% | 0.01% |
| March 15, 2024 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Stock Option (right to buy) | 11500 | $0.00 | 11,500.0000 | 48,737,377 | 9999.99% | 0.02% |
| March 9, 2024 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Common Stock | 2666 | $0.00 | 75,791.0000 | 48,737,377 | 3.65% | 0.01% |
| March 11, 2024 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1418 | $16.35 | 74,373.0000 | 48,737,377 | 1.87% | 0.00% |
| March 15, 2024 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1312 | $15.43 | 73,061.0000 | 48,737,377 | 1.76% | 0.00% |
| March 15, 2024 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Common Stock | 5750 | $0.00 | 78,811.0000 | 48,737,377 | 7.87% | 0.01% |
| Sept. 12, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Common Stock | 1000 | $12.79 | 73,125.0000 | 48,709,384 | 1.39% | 0.00% |
| Sept. 12, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Stock Option (right to buy) | 1000 | $0.00 | 89,000.0000 | 48,709,384 | 1.11% | 0.00% |
| March 22, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Stock Option (right to buy) | 20910 | $0.00 | 20,910.0000 | 48,987,295 | 9999.99% | 0.04% |
| March 22, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | A | Common Stock | 10455 | $0.00 | 72,125.0000 | 48,987,295 | 16.95% | 0.02% |
| March 15, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1362 | $20.79 | 61,670.0000 | 48,987,295 | 2.16% | 0.00% |
| March 9, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Restricted Stock Rights | 2667 | $0.00 | 5,333.0000 | 48,987,295 | 33.34% | 0.01% |
| March 9, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | M | Common Stock | 2667 | $0.00 | 64,508.0000 | 48,987,295 | 4.31% | 0.01% |
| March 13, 2023 | Cryoport, Inc. | $CYRX | Sawicki Mark W | Chief Scientific Officer | S | Common Stock | 1476 | $20.14 | 63,032.0000 | 48,987,295 | 2.29% | 0.00% |